Tracleer

Get information about Tracleer treatment, benefits and side effects for PPH (primary pulmonary hypertension). Tracleer is the first oral medication approved for treatment of PAH (pulmonary arterial hypertension). Aside from Tracleer, several other new prescription drugs have been designed for treatment of PPH. Tracleer can slow the worsening of a patient's physical condition and symptoms. Tracleer is an oral medication, so it is taken in a tablet form. Tracleer is very likely to cause major birth defects. Tracleer (bosentan) is an oral endothelin receptor. Actelion is the company that makes Tracleer. Tracleer is a registered trademark.